Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Plans Quarterly Dividend of $0.30

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) declared a quarterly dividend on Wednesday, May 8th, Zacks reports. Stockholders of record on Monday, May 20th will be paid a dividend of 0.30 per share by the real estate investment trust on Friday, May 31st. This represents a $1.20 dividend on an annualized basis and a dividend yield of 8.28%. The ex-dividend date of this dividend is Friday, May 17th.

Sabra Health Care REIT has decreased its dividend payment by an average of 3.9% annually over the last three years and has raised its dividend every year for the last 2 years. Sabra Health Care REIT has a dividend payout ratio of 187.5% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Research analysts expect Sabra Health Care REIT to earn $1.44 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 83.3%.

Sabra Health Care REIT Price Performance

Shares of SBRA stock remained flat at $14.49 during trading hours on Friday. 289,528 shares of the stock were exchanged, compared to its average volume of 2,019,596. The company has a debt-to-equity ratio of 0.86, a quick ratio of 3.41 and a current ratio of 3.41. The firm has a market cap of $3.35 billion, a P/E ratio of 289.80, a price-to-earnings-growth ratio of 5.15 and a beta of 1.17. The business has a fifty day moving average price of $14.15 and a two-hundred day moving average price of $14.04. Sabra Health Care REIT has a 12 month low of $10.30 and a 12 month high of $14.92.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on SBRA shares. Deutsche Bank Aktiengesellschaft started coverage on shares of Sabra Health Care REIT in a research note on Tuesday, January 30th. They set a “buy” rating and a $21.00 price target for the company. Wedbush reissued an “outperform” rating and set a $17.00 price target on shares of Sabra Health Care REIT in a research note on Thursday, February 29th. Five investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $15.77.

Sabra Health Care REIT Company Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.